CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,614
- in 3 filings
Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-14 | Shah Gaurav CEO | Grant or award · Restricted Stock Units | +116,317 | 116,317 | ||
| 2023-02-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | +31,440 | 63,835 | ||
| 2023-02-14 | Wilson Martin General Counsel | Grant or award · Stock Option (Right to Buy) | +87,147 | 87,147 | ||
| 2023-02-14 | Wilson Martin General Counsel | Grant or award · Restricted Stock Units | +29,079 | 29,079 | ||
| 2023-02-14 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +49,798 | 49,798 | ||
| 2023-02-14 | Militello John See Remarks | Grant or award · Restricted Stock Units | +16,616 | 16,616 | ||
| 2023-02-14 | Schwartz Jonathan David See Remarks | Grant or award · Stock Option (Right to Buy) | +124,496 | 124,496 | ||
| 2023-02-14 | Schwartz Jonathan David See Remarks | Grant or award · Restricted Stock Units | +41,541 | 41,541 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Grant or award · Stock Option (Right to Buy) | +199,194 | 199,194 | ||
| 2023-02-14 | Patel Kinnari See Remarks | Grant or award · Restricted Stock Units | +66,467 | 66,467 | ||
| 2023-02-14 | Shah Gaurav CEO | Grant or award · Stock Option (Right to Buy) | +348,590 | 348,590 | ||
| 2023-02-14 | Shah Gaurav CEO | Grant or award · Restricted Stock Units | +116,317 | 116,317 | ||
| 2022-12-23 | RTW INVESTMENTS, LP 10% owner | Other acquisition · Notional Derivative Agreements (obligation to buy) | +1 | 1 | ||
| 2022-12-22 | RTW INVESTMENTS, LP Director | Other acquisition · Notional Derivative Agreements (obligation to buy) | +1 | 1 | ||
| 2022-12-01 | RTW INVESTMENTS, LP 10% owner | Other acquisition | +529,038 | 18,157,605 | ||
| 2022-12-01 | RTW INVESTMENTS, LP 10% owner | Other acquisition · Warrants | +61,705 | 61,705 | ||
| 2022-10-06 | RTW INVESTMENTS, LP Director | Purchase | +1,355,932 | $14.75 | $20.0M | 17,628,567 |
| 2022-08-12 | Wilson Martin General Counsel | Other acquisition | +28,763 | 49,863 | ||
| 2022-08-12 | Wilson Martin General Counsel | Other disposition · Restricted Stock Units | −28,763 | 0 | ||
| 2022-08-12 | Patel Kinnari See Remarks | Other acquisition | +52,489 | 366,283 |
Page 18 of 19 · 374 trades